A novel spasmolytic and CNS active agent: 3-(2-benzylmethylamino ethyl) benzoic acid methyl ester hydrochloride.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D003213:Conditioning, Psychological / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006339:Heart Rate / Q000187:drug effects; D007858:Learning / Q000187:drug effects*; D008568:Memory / Q000187:drug effects; D008694:Methamphetamine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D014706:Verbal Learning / Q000187:drug effects
D010276:Parasympatholytics; D008694:Methamphetamine; D001058:Apomorphine